Table of Contents

company-logo

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Dividend Announcement

• GeneDx does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on GeneDx dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

GeneDx Dividend Yield

GeneDx current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing GeneDx stock? Use our calculator to estimate your expected dividend yield:

GeneDx Financial Ratios

P/E ratio-23.82
PEG ratio3.56
P/B ratio9.72
ROE-40.06%
Payout ratio0.00%
Current ratio2.41
Quick ratio2.27
Cash Ratio0.75

GeneDx Dividend FAQ

Does GeneDx stock pay dividends?
GeneDx does not currently pay dividends to its shareholders.
Has GeneDx ever paid a dividend?
No, GeneDx has no a history of paying dividends to its shareholders. GeneDx is not known for its dividend payments.
Why doesn't GeneDx pay dividends?
There are several potential reasons why GeneDx would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will GeneDx ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While GeneDx has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is GeneDx a dividend aristocrat?
GeneDx is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is GeneDx a dividend king?
GeneDx is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is GeneDx a dividend stock?
No, GeneDx is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy GeneDx stocks?
To buy GeneDx you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy GeneDx stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.